IGM Biosciences, Inc.
IGMSDelisted Aug 14, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001496323
IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding IGM Biosciences, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 72 | 87 | +15 |
| Shares | 21.9M | 22.8M | +916.4K (+4.2%) |
| Value | $182.1M | $220.3M | +$38.2M (+21.0%) |
New holders (26)
Institutions that held IGM Biosciences, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (11)
Institutions that held IGM Biosciences, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 400,000 | $3.32M |
| Exome Asset Management LLC | 135,596 | $1.13M |
| Hudson Bay Capital Management LP | 124,260 | $1.03M |
| Prudential Financial Inc | 65,870 | $547.4K |
| State of Wisconsin Investment Board | 29,600 | $246.0K |
| Prelude Capital Management, LLC | 29,421 | $244.5K |
| Susquehanna International Group, LLP | 13,656 | $113.5K |
| Amundi | 9,196 | $107.1K |
| Acadian Asset Management LLC | 8,367 | $69.0K |
| Simplex Trading, LLC | 1,810 | $15.0K |
| Northwestern Mutual Wealth Management Co | 500 | $4.16K |